Desjardins Global Asset Management Inc. Boston Scientific Corp Transaction History
Desjardins Global Asset Management Inc.
- $922 Million
- Q4 2023
A detailed history of Desjardins Global Asset Management Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Desjardins Global Asset Management Inc. holds 42,868 shares of BSX stock, worth $3.81 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
42,868
Previous 42,409
1.08%
Holding current value
$3.81 Million
Previous $2.24 Million
10.67%
% of portfolio
0.27%
Previous 0.25%
Shares
9 transactions
Others Institutions Holding BSX
# of Institutions
1,542Shares Held
1.19BCall Options Held
6.79MPut Options Held
10.1M-
Vanguard Group Inc Valley Forge, PA131MShares$11.7 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$11.2 Billion0.22% of portfolio
-
State Street Corp Boston, MA62.8MShares$5.59 Billion0.22% of portfolio
-
Primecap Management CO Pasadena, CA37.8MShares$3.36 Billion2.37% of portfolio
-
Wellington Management Group LLP Boston, MA32.8MShares$2.92 Billion0.49% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $127B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...